Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers



  Free Subscription

Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 28 articles:
HTML format

Single Articles

    March 2020
  1. MA W, Guo X, Wang Q, Sun G, et al
    Systematic Review and Meta-analysis Appraising Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2020 Mar 26. doi: 10.1097/FJC.0000000000000832.
    PubMed     Abstract available

    February 2020
  2. WANG S, Li B, Li X, Wu L, et al
    Low-intensity ultrasound modulation may prevent myocardial infarction induced sympathetic neural activation and ventricular arrhythmia.
    J Cardiovasc Pharmacol. 2020 Feb 17. doi: 10.1097/FJC.0000000000000810.
    PubMed     Abstract available

  3. VERRIER RL, Belardinelli L
    Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2020 Feb 5. doi: 10.1097/FJC.0000000000000804.
    PubMed     Abstract available

    January 2020
  4. ZHOU D, Yang K, Hu J, Shi J, et al
    Noncoding RNAs in Atrial Fibrillation: Current Status and Prospect.
    J Cardiovasc Pharmacol. 2020;75:10-17.
    PubMed     Abstract available

    December 2019
  5. SCHNIERER M, Samos M, Bolek T, Skornova I, et al
    The effect of PPI withdrawal on dabigatran etexilate plasma levels in patients with atrial fibrillation: a washout study.
    J Cardiovasc Pharmacol. 2019 Dec 30. doi: 10.1097/FJC.0000000000000791.
    PubMed     Abstract available

  6. MELILLO E, Carbone A, Rago A, Papa AA, et al
    Update on Direct oral anticoagulants in atrial fibrillation patients undergoing cardiac interventional procedures: from clinical trials to real-world evidence.
    J Cardiovasc Pharmacol. 2019 Dec 12. doi: 10.1097/FJC.0000000000000786.
    PubMed     Abstract available

    November 2019
  7. MARUM AA, Silva BA, Bortolotto AL, Pedreira GC, et al
    Pulmonary Delivery of Metoprolol Reduces Ventricular Rate during Atrial Fibrillation and Accelerates Conversion to Sinus Rhythm.
    J Cardiovasc Pharmacol. 2019 Nov 25. doi: 10.1097/FJC.0000000000000780.
    PubMed     Abstract available

  8. WANG C, Yu S, Bao Q, Qiang W, et al
    Circulating Mesencephalic Astrocyte-derived Neurotrophic Factor Negatively Correlates with Atrial Apoptosis in Human Chronic Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2019 Nov 25. doi: 10.1097/FJC.0000000000000781.
    PubMed     Abstract available

    September 2019
  9. DOMEK M, Gumprecht J, Mazurek M, Chao TF, et al
    Should we judge stroke risk by static or dynamic risk scores? A focus on the dynamic nature of stroke and bleeding risks in patients with atrial fibrillation.
    J Cardiovasc Pharmacol. 2019 Sep 14. doi: 10.1097/FJC.0000000000000750.
    PubMed     Abstract available

  10. YAMAJI H, Higashiya S, Murakami T, Hina K, et al
    Effects of Oral Anticoagulants on Patients With Atrial Fibrillation Aged 90 Years and Older: Comparison Among Direct Oral Anticoagulant, Warfarin Anticoagulant, and Nonanticoagulation.
    J Cardiovasc Pharmacol. 2019;74:246-254.
    PubMed     Abstract available

    July 2019
  11. YAMAJI H, Higashiya S, Murakami T, Hina K, et al
    Effects of oral anticoagulants on >/=90-year-old atrial fibrillation patients: comparison among direct oral anticoagulant, warfarin anticoagulant, and non-anticoagulation.
    J Cardiovasc Pharmacol. 2019 Jul 22. doi: 10.1097/FJC.0000000000000703.
    PubMed     Abstract available

  12. MISHRA A, Singh M, Acker WW, Kamboj S, et al
    Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    J Cardiovasc Pharmacol. 2019 Jul 11. doi: 10.1097/FJC.0000000000000697.
    PubMed     Abstract available

    February 2019
  13. RUSSO V, Carbone A, Rago A, Golino P, et al
    Direct Oral Anticoagulants in octogenarians with atrial fibrillation: it's never too late.
    J Cardiovasc Pharmacol. 2019 Feb 26. doi: 10.1097/FJC.0000000000000661.
    PubMed     Abstract available

  14. SCHUPP T, Behnes M, Weiss C, Nienaber C, et al
    Prognostic Impact of Angiotensin Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and ICD Therapies.
    J Cardiovasc Pharmacol. 2019 Feb 8. doi: 10.1097/FJC.0000000000000659.
    PubMed     Abstract available

    January 2019
  15. YI F, Hou W, Zhou C, Yin Y, et al
    Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Safety and efficacy1.
    J Cardiovasc Pharmacol. 2019 Jan 25. doi: 10.1097/FJC.0000000000000654.
    PubMed     Abstract available

    December 2018
  16. GIANNOPOULOS G, Vrachatis D, Kossyvakis C, Angelidis C, et al
    Effect of Postablation Statin Treatment on Arrhythmia Recurrence in Patients With Paroxysmal Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2018;72:285-290.
    PubMed     Abstract available

    June 2018
  17. JANION-SADOWSKA A, Papuga-Szela E, Lukaszuk R, Chrapek M, et al
    Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and thrombocytopenia.
    J Cardiovasc Pharmacol. 2018 Jun 27. doi: 10.1097/FJC.0000000000000607.
    PubMed     Abstract available

    May 2018
  18. CHANG PC, Lu YY, Lee HL, Lin SF, et al
    Paradoxical Effects of Sodium-Calcium Exchanger Inhibition on Torsade de Pointes and Early Afterdepolarization in a Heart Failure Rabbit Model.
    J Cardiovasc Pharmacol. 2018 May 3. doi: 10.1097/FJC.0000000000000598.
    PubMed     Abstract available

    March 2018
  19. CHENG W, Liu W, Li B, Li D, et al
    Relations of Anticoagulant Therapy with Cognitive Impairment among Patients with Atrial Fibrillation: A Meta-Analysis and Systematic Review.
    J Cardiovasc Pharmacol. 2018 Mar 2. doi: 10.1097/FJC.0000000000000575.
    PubMed     Abstract available

    February 2018
  20. ISHIZAKA T, Yoshimatsu Y, Maeda Y, Chiba K, et al
    Inotropic Effects of Nicorandil on Cardiac Contractility Assessed by Left Ventricular Pressure-Volume Relationship Analyses in Anesthetized Monkeys.
    J Cardiovasc Pharmacol. 2018;71:76-81.
    PubMed     Abstract available

    October 2017
  21. CARSTENSEN H, Kjaer L, Haugaard MM, Flethoj M, et al
    Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses.
    J Cardiovasc Pharmacol. 2017 Oct 25. doi: 10.1097/FJC.0000000000000541.
    PubMed     Abstract available

  22. CHOI J, Kim J, Shim JH, Kim M, et al
    Risks Versus Benefits of Anticoagulation for Atrial Fibrillation in Cirrhotic Patients.
    J Cardiovasc Pharmacol. 2017;70:255-262.
    PubMed     Abstract available

    July 2017
  23. DE VRIES LJ, Geczy T, Szili-Torok T
    Sleep medications containing melatonin can potentially induce ventricular arrhythmias in structurally normal hearts: a two-patient report.
    J Cardiovasc Pharmacol. 2017 Jul 13. doi: 10.1097/FJC.0000000000000515.
    PubMed     Abstract available

  24. BANOVCIN P JR, Skornova I, Samos M, Schnierer M, et al
    Platelet aggregation in direct oral factor Xa inhibitors-treated patients with atrial fibrillation: a pilot study.
    J Cardiovasc Pharmacol. 2017 Jul 13. doi: 10.1097/FJC.0000000000000516.
    PubMed     Abstract available

  25. ZHONG P, Quan D, Huang Y, Huang H, et al
    CaMKII activation promotes cardiac electrical remodeling and increases the susceptibility to arrhythmia induction in high fat diet-fed mice with hyperlipidemia conditions.
    J Cardiovasc Pharmacol. 2017 Jul 4. doi: 10.1097/FJC.0000000000000512.
    PubMed     Abstract available

    June 2017
  26. BOSSU A, Varkevisser R, Beekman HDM, Houtman MJC, et al
    Short-term Variability of Repolarization Is Superior to Other Repolarization Parameters in the Evaluation of Diverse Antiarrhythmic Interventions in the Chronic Atrioventricular Block Dog.
    J Cardiovasc Pharmacol. 2017;69:398-407.
    PubMed     Abstract available

    May 2017
  27. VECSERNYES M, Szokol M, Bombicz M, Priksz D, et al
    Alpha-Melanocyte-stimulating Hormone Induces Vasodilation and Exerts Cardioprotection Through the Heme-Oxygenase Pathway in Rat Hearts.
    J Cardiovasc Pharmacol. 2017;69:286-297.
    PubMed     Abstract available

    March 2017
  28. LIU Y, Scherlag BJ, Fan Y, Xia W, et al
    Acetylcholine-Atropine Interactions: Paradoxical Effects on Atrial Fibrillation Inducibility.
    J Cardiovasc Pharmacol. 2017 Mar 21. doi: 10.1097/FJC.0000000000000484.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.